These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endometrial cancer as an estrogen-progesterone target. Richardson GS N Engl J Med; 1972 Mar; 286(12):645-7. PubMed ID: 4551276 [No Abstract] [Full Text] [Related]
3. Endometrial cancer. Facts and theories. Nordqvist SR Pathol Annu; 1973; 8():283-300. PubMed ID: 4355361 [No Abstract] [Full Text] [Related]
4. Interaction of ovarian hormones with normal endometrium and endometrial adenocarcinoma. Gurpide E; Holinka CF; Fleming H; Fridman O; Deligdisch L; Deppe G Mt Sinai J Med; 1980; 47(4):394-7. PubMed ID: 6968031 [TBL] [Abstract][Full Text] [Related]
5. Early stages in estrogen control of gene expression and its derangement in cancer. Bresciani F; Nola E; Sica V; Puca GA Fed Proc; 1973 Nov; 32(11):2126-32. PubMed ID: 4359599 [No Abstract] [Full Text] [Related]
6. Proceedings: The mechanism of action of estrogens. Rosner JM; Pedroza García E; García Bienere W Acta Physiol Lat Am; 1973; 23(6):463-4. PubMed ID: 4369067 [No Abstract] [Full Text] [Related]
7. Clinical significance of estrogen receptors in human breast cancer. Olsnes S; Pihl A Biomedicine; 1974 Nov; 20(6):377-83. PubMed ID: 4376029 [No Abstract] [Full Text] [Related]
8. [Study on endocrine function in myoma of the uterus with special reference to the urinary excretion of pituitary gondotropins]. Takano J Nihon Sanka Fujinka Gakkai Zasshi; 1965 Feb; 17(2):119-28. PubMed ID: 5895428 [No Abstract] [Full Text] [Related]
10. [Proceedings: Fluctuation of estrogen receptor numbers in target organs]. Ota M; Kuzuya K; Ito K; Hiroshima T; Tomita E Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):492. PubMed ID: 4375611 [No Abstract] [Full Text] [Related]
11. [Molecular mechanisms of cytoreception of estrogens]. Sergeev PV; Maĭskiĭ AI; Ogurtsov SI Usp Sovrem Biol; 1974; 78(1):107-21. PubMed ID: 4373978 [No Abstract] [Full Text] [Related]
12. Oestrogen-binding and the hormone respinsiveness of tumours. King RJ; Smith JA; Steggles AW Steroidologia; 1970; 1(2):73-88. PubMed ID: 4938760 [No Abstract] [Full Text] [Related]
13. Proceedings: Interaction of androgens with the oestrogen receptor in human myometrial and in mammary cancer tissue. Poortman J Horm Res; 1975; 6(5-6):306-7. PubMed ID: 181316 [No Abstract] [Full Text] [Related]
14. [In-vitro and in-vivo modification of uterine cytoplasmatic estrogen-receptors in female calves through hormonal anabolics]. Kyrein HJ; Hoffmann B Fortschr Tierphysiol Tierernahr; 1976; (6):91-8. PubMed ID: 185131 [No Abstract] [Full Text] [Related]
15. Estrogen receptors: physiology and clinical applications. André J; Rochefort H Eur J Obstet Gynecol Reprod Biol; 1974; 4(2):67-81. PubMed ID: 4370004 [No Abstract] [Full Text] [Related]
16. [Proceedings: Comparison between estrogen-binding-proteins of pituitary tumor tissue and of the normal pituitary gland and uterus of the rat]. Watanabe T; Takaya O; Ikeda T; Kumaoka S; Abe K Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):490. PubMed ID: 4476525 [No Abstract] [Full Text] [Related]
17. [Cancer of the corpus uteri as a manifestation of hypothalamic pathology]. Dil'man VM; Bershteĭn LM; Bobrov IuF; Bokhman IaV; Kovaleva IG; Krylova NV Vopr Onkol; 1967; 13(11):39-44. PubMed ID: 5597521 [No Abstract] [Full Text] [Related]
19. [Comparative characteristics of specific binding of estradiol-17beta with proteins-receptors in CBA and C57Bl/6 murine line uterine cytosol during sarcomagenesis induced by 1,2-dimethylhydrazine]. Morozova OV; Kushlinskiĭ NE Biull Eksp Biol Med; 1995 Jan; 119(1):58-62. PubMed ID: 7718806 [No Abstract] [Full Text] [Related]
20. [Presence of estrogen-binding systems in the plasma membranes of rat uterus cells]. Sergeev PV; Denisov IuP; Suleĭmanov SSh Farmakol Toksikol; 1981; 44(4):429-32. PubMed ID: 7286201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]